Pharsight

Drug Patent Number	Company	Drug Patent Title	Drug Patent Expiry	Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5708011	PURDUE PHARMA LP	Use of levobupivacaine in a patient having depressed myocardial contractility	Oct, 2014 (9 years ago)

Chirocaine is owned by Purdue Pharma Lp.

Chirocaine contains Levobupivacaine Hydrochloride.

Chirocaine has a total of 1 drug patent out of which 1 drug patent has expired.

Expired drug patents of Chirocaine are:

Chirocaine was authorised for market use on 05 August, 1999.

Chirocaine is available in injectable;injection dosage forms.

Chirocaine can be used as method of use of levobupivacaine.

The generics of Chirocaine are possible to be released after 13 October, 2014.

Market Authorisation Date: 05 August, 1999

Treatment: Method of use of levobupivacaine

Dosage: INJECTABLE;INJECTION

Strength	Dosage	Availability
EQ 2.5MG BASE/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE;INJECTION	Discontinued
EQ 5MG BASE/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE;INJECTION	Discontinued
EQ 7.5MG BASE/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE;INJECTION	Discontinued

Chirocaine patents expiration